Although there are scant published data discussing the safety in pregnant women with chronic HBV infection, IFN has been recommended widely in MS, ET, chronic myeloid leukemia, multiple myeloma, and others (46–48). The gene discussed is IFNA1; the disease is plasma cell myeloma.